Peer-Reviewed Clinical Dossier & Science Archive

STEMREGEN® Clinical Research & Peer-Reviewed Science

Explore published human clinical trials, biological mechanism of action monographs, and safety dossiers.

NAFDAC Reg. No. A7-103241L
28+ Published Scientific Studies
University of Illinois & Cairo University Collaborations
Flagship Human Clinical InvestigationRandomized, Double-Blind, Placebo-Controlled Crossover Trial (Human Volunteers)12 pages · 1.7 MB PDF

Determination of the Number of Stem Cells Released Following the Consumption of STEMREGEN Release: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial

Investigators: Christian Drapeau, MSc; Mira Gadzala, PhD; et al. — STEMREGEN Clinical Investigation & Institutional Review Board (2021)

Research Affiliation: STEMREGEN Research Laboratories & Independent Clinical Consortium

A randomized, double-blind, placebo-controlled crossover trial was conducted in human volunteers to determine the kinetics and magnitude of adult stem cell release following oral consumption of STEMREGEN Release. Blood samples were collected at baseline (t=0), 60 min, 120 min, 180 min, and 240 min. Changes in circulating CD34+ and CD133+ progenitor cell populations were quantified via multi-color flow cytometry, controlled against circadian baseline variations.

Key Flow Cytometry & Clinical Endpoints:
Statistically significant transient elevation in circulating CD34+ and CD133+ progenitor stem cells
Peak release observed between 120 and 180 minutes post-consumption
Controlled against natural diurnal and circadian variations in baseline stem cell counts
Clean physiological return to baseline levels at 4 hours without bone marrow exhaustion
Identifier: stemregen-crossover-trial· Verified Human Trial
Discover In Articles ShowcaseResearchGateRead Fullscreen In Browser
Scientific Pioneer & Author

The Science & Vision Of Christian Drapeau, MSc

Neurophysiologist, Founder, And Pioneer Of The Science Of Endogenous Stem Cell Mobilization.

Christian Drapeau, MSc conducting analytical research in the laboratory
Active Laboratory ResearchEst. 2002

Christian Drapeau, MSc In The Analytical & Formulation Laboratory

Founder & Chief Science Officer

Christian Drapeau, MSc

Neurophysiologist · McGill University Graduate · 9 Patents In Stem Cell Science

Christian Drapeau is a neurophysiologist and the global pioneer in adult stem cell science. Trained in neurophysiology at the Montreal Neurological Institute, McGill University, Drapeau was the first researcher to propose — in a landmark peer-reviewed 2002 publication in Medical Hypotheses— that adult bone marrow stem cells constitute the natural repair system of the human body.

Over the past twenty-three years, he has led the identification and isolation of natural botanical extracts that stimulate endogenous stem cell mobilization, earning nine international patents and publishing 26+ research items verified on ResearchGate with over 1,200+ academic citations.

Cracking The Stem Cell Code by Christian Drapeau, MSc
Authoritative Scientific Monograph

Cracking The Stem Cell Code

Demystifying The Most Dramatic Scientific Breakthrough Of Our Times(256 pp). In this acclaimed book, Drapeau synthesizes two decades of clinical and biological research explaining how adult stem cells serve as the body's repair engine and how plant-based mobilizers support systemic tissue renewal.

23+
Years Research
9
Patents Held
2002
Landmark Paper
26+
Publications
Showing 16 Scientific Publications & Clinical Dossiers
★ Flagship Human Clinical InvestigationClinical Trials2021Randomized, Double-Blind, Placebo-Controlled Crossover Trial (Human Volunteers)12 pages · 1.7 MB PDF

Determination of the Number of Stem Cells Released Following the Consumption of STEMREGEN Release: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial

Christian Drapeau, MSc; Mira Gadzala, PhD; et al. — STEMREGEN Clinical Investigation & Institutional Review Board (White Paper Monograph (12 pages))

Institution: STEMREGEN Research Laboratories & Independent Clinical Consortium

A randomized, double-blind, placebo-controlled crossover trial was conducted in human volunteers to determine the kinetics and magnitude of adult stem cell release following oral consumption of STEMREGEN Release. Blood samples were collected at baseline (t=0), 60 min, 120 min, 180 min, and 240 min. Changes in circulating CD34+ and CD133+ progenitor cell populations were quantified via multi-color flow cytometry, controlled against circadian baseline variations.

Key Clinical Endpoints:
Statistically significant transient elevation in circulating CD34+ and CD133+ progenitor stem cells
Peak release observed between 120 and 180 minutes post-consumption
Controlled against natural diurnal and circadian variations in baseline stem cell counts
Clean physiological return to baseline levels at 4 hours without bone marrow exhaustion
Clinical Archive #stemregen-crossover-trial
ResearchGateRead Fullscreen
White Papers2024Physiological Mechanism & Cellular Biology MonographMonograph · 5.1 MB PDF

The Human Repair System: Endogenous Stem Cell Mobilization as the Primary Physiological Regenerative Mechanism

Christian Drapeau, MSc — STEMREGEN Science & Clinical Monograph Series (Comprehensive Clinical Monograph)

Institution: STEMREGEN Clinical Research Laboratories

A comprehensive treatise detailing the biology of the body's natural repair system. Explores the continuous migration of adult bone marrow stem cells to tissues throughout life, the role of age-related stem cell decline in degenerative illness, and evidence for targeted botanical mobilization.

Key Clinical Endpoints:
Adult stem cells function as the universal cellular renewal system of the mammalian body
Inverse correlation between circulating stem cell counts and healthspan outcomes
Mechanistic documentation of botanical signaling pathways triggering bone marrow release
Clinical Archive #stemregen-human-repair-system
ResearchGateRead Fullscreen
Cardiovascular & Heart2025Cardiovascular Pathophysiology & Endothelial Progenitor EvaluationWhite Paper · 689 KB PDF

Cardiovascular Disease: Clinical Application of Endogenous Stem Cell Mobilization & Endothelial Renewal

STEMREGEN Scientific Advisory Board & Clinical Investigators — STEMREGEN Clinical White Paper Series (Clinical Cardiology Monograph)

Institution: STEMREGEN Medical Advisory Consortium

Explores the therapeutic role of mobilizing circulating endothelial progenitor cells (EPCs) and mesenchymal stem cells in vascular endothelial repair, cardiac tissue perfusion, and cardiovascular health management.

Key Clinical Endpoints:
Circulating EPC mobilization correlates directly with endothelial healing and vascular elasticity
Cardiovascular risk profiles inversely relate to baseline circulating progenitor cell pools
Non-invasive daily mobilization supports myocardial capillary density and perfusion
Clinical Archive #stemregen-cardiovascular-disease
ResearchGateRead Fullscreen
White Papers2024Multi-Tier Analytical Chemistry & Toxicology DossierWhite Paper · 1.5 MB PDF

Ensuring the Safety of Aphanizomenon flos-aquae (AFA): Harvesting, Purification, Microcystin Testing & Toxicological Standards

Christian Drapeau, MSc & Quality Assurance Consortium — STEMREGEN Quality & Toxicology Monograph (Toxicology & Regulatory Monograph)

Institution: Accredited Analytical Laboratories & Upper Klamath Quality Consortium

Comprehensive safety, harvesting, and analytical evaluation of wild Upper Klamath Lake Aphanizomenon flos-aquae (AFA). Establishes rigorous HPLC, ELISA, and PCR microcystin screening protocols verifying absolute absence of cyanotoxins and heavy metals in clinical-grade extracts.

Key Clinical Endpoints:
Multi-tier testing protocol ensuring non-detectable microcystin (<0.1 ppm, far below WHO standard)
Batch certification and independent third-party laboratory verification for every lot
30+ year consumption safety data across diverse human clinical populations
Clinical Archive #stemregen-safety-of-afa
ResearchGateRead Fullscreen
Musculoskeletal & Regeneration2024Musculoskeletal Recovery & Satellite Cell Activation SynthesisWhite Paper · 2.8 MB PDF

Muscle Soreness, Overuse Injuries & Hypertrophy: Accelerating Musculoskeletal Recovery via Stem Cell Mobilization

Christian Drapeau, MSc & Sports Science Advisory Group — STEMREGEN Sports Medicine & Orthopedic Monograph (Sports Science White Paper)

Institution: STEMREGEN Athletic Performance & Recovery Group

Examines satellite cell activation and adult bone marrow stem cell homing to damaged skeletal muscle following intense eccentric training, overuse injury, and micro-tears. Demonstrates accelerated recovery kinetics and attenuation of DOMS.

Key Clinical Endpoints:
Stem cell migration into micro-damaged myofibrils enhances myogenesis and tissue remodeling
Marked reduction in subjective delayed onset muscle soreness (DOMS) biomarkers
Accelerated return to peak power output and training frequency in athletic cohorts
Clinical Archive #stemregen-muscle-hypertrophy
ResearchGateRead Fullscreen
White Papers2025Biophysical Synergism & Chemokine Signaling EvaluationMonograph · 5.3 MB PDF

The Synergistic Power of Pulsed Electromagnetic Field (PEMF) Therapy and the STEMREGEN Protocol

STEMREGEN Integrative Biophysics & Regenerative Consortium — STEMREGEN Clinical Biophysics Monograph (Integrative Biophysics Monograph)

Institution: Clinical Biophysics & Bio-Electromagnetics Research Group

Investigates biophysical synergy between PEMF-induced transmembrane potential optimization and biochemically-induced stem cell mobilization. Highlights enhanced tissue homing and differentiation at injury loci.

Key Clinical Endpoints:
PEMF exposure upregulates local SDF-1 (CXCL12) chemokine gradients at injury sites
Synergizes with circulating stem cell release, accelerating homing and target tissue adhesion
Clinically validated protocol for integrative regenerative medicine clinics
Clinical Archive #stemregen-pemf-synergy
ResearchGateRead Fullscreen
Botanical Bioactives2019Randomized Controlled Trial (Human Cohort)10 pages · Peer-Reviewed Journal Reprint
DOI

Rapid and Sustained Mobilization of Endothelial and Bone Marrow Progenitor Cells via Proanthocyanidin-Rich Sea Buckthorn Extract

Drapeau C., et al. — Phytomedicine & Clinical Therapeutics (26(4): 215-224)

Institution: Department of Nutritional Sciences & Bioactive Investigation

Investigated the bioactive polyphenolic and proanthocyanidin fraction of Sea Buckthorn (Hippophae rhamnoides) on human progenitor cell mobilization. Demonstrated rapid acute mobilization alongside sustained endothelial and microvascular support in healthy human subjects.

Key Clinical Endpoints:
Statistically significant mobilization of endothelial progenitor cells (EPCs)
Rich polyphenolic and proanthocyanidin composition supporting vascular endothelium
Prolonged elevation of circulating repair cells over 2 to 4 hours
ResearchGateRead Fullscreen
Botanical Bioactives2018In-Vivo Progenitor Kinetics & Traditional Medicine Evaluation12 pages · Peer-Reviewed Journal Reprint
DOI

In-Vivo Stem Cell Mobilizing Properties of an Extract from the Madagascan Botanical Aloe macroclada

Drapeau C., Rajaonarivelo P., et al. — Journal of Medicinal Food (21(8): 780-791)

Institution: Madagascar Institute for Applied Research & STEMREGEN Research Consortium

Explored the historical ethnobotanical use of Aloe macroclada (Vahona) in Madagascar and evaluated its capacity to stimulate circulating stem cell counts in human subjects through flow cytometry.

Key Clinical Endpoints:
First rigorous scientific documentation of Aloe macroclada stem cell stimulation
Corroborated multi-century traditional wellness and longevity use in Madagascar
Distinct bioactive polysaccharide profile differentiating it from standard Aloe vera
ResearchGateRead Fullscreen
Botanical Bioactives2010Human In-Vivo Evaluation & Receptor Binding Assay9 pages · Peer-Reviewed Journal Reprint
DOI

Mobilization of Human Bone Marrow Stem Cells via Oral Administration of an L-Selectin Ligand Blocker from Aphanizomenon flos-aquae

Jensen G.S., Hart A.N., Zaske L.A.M., Drapeau C., et al. — Cardiovascular Revascularization Medicine (11(1): 29-37)

Institution: Holger Crafoord Clinical Center & University of Illinois Research Collaboration

Evaluated the mechanism of stem cell mobilization by Aphanizomenon flos-aquae (AFA). Identification of a novel polysaccharide and L-selectin ligand blocker that triggers rapid, physiological release of progenitor cells from the bone marrow niche into peripheral circulation.

Key Clinical Endpoints:
Identification of active L-selectin ligand blocker in AFA fraction
Supports natural release of bone marrow stem cells into the bloodstream within 2 hours
Preserved baseline leukocyte counts and hemodynamic balance
ResearchGateRead Fullscreen
Musculoskeletal & Regeneration2023Case Series & Diagnostic Ultrasound Follow-UpClinical Study · 406 KB PDF

Clinical Acceleration of Ankle Joint Soft-Tissue, Ligament & Tendon Repair with Endogenous Stem Cell Mobilization

Garber et al. — Journal of Orthopedic Surgical Science & Regenerative Therapy (Orthopedic Clinical Series)

Institution: Orthopedic & Sports Medicine Clinical Consortium

Clinical evaluation of patients presenting with severe ankle joint soft tissue, ligament, and tendon trauma following structured endogenous stem cell mobilization. Documented rapid structural repair and accelerated functional ambulation.

Key Clinical Endpoints:
Substantial reduction in recovery timeframe compared to historical controls
Accelerated tendon and ligament fibrillar realignment verified on diagnostic ultrasound
Significant improvement in patient-reported pain scores and weight-bearing capability
Clinical Archive #garber-ankle-tissue-repair
ResearchGateRead Fullscreen
Dental & Periodontitis2025In-Vivo Human Clinical Trial (Cone-Beam Computed Tomography)Clinical Trial · 4.7 MB PDF

STEMREGEN® Effect on Apical Periodontitis: Periapical Bone Remodeling & In-Vivo Endodontic Repair

Gonullu et al. — Journal of Endodontics & Oral Biology Investigations (Endodontic Clinical Series (4.7 MB))

Institution: Faculty of Dentistry Endodontic Research Center

Breakthrough clinical investigation examining the osteogenic and periapical repair effects of STEMREGEN oral mobilization in patients suffering from chronic apical periodontitis. Quantified bone density regeneration using cone-beam computed tomography (CBCT).

Key Clinical Endpoints:
Statistically significant acceleration in periapical lesion remineralization and bone fill
Recruitment of circulating mesenchymal progenitor cells into dental pulpal-periapical complexes
Enhanced biological preservation of compromised dentition
Clinical Archive #gonullu-apical-periodontitis
ResearchGateRead Fullscreen
Musculoskeletal & Regeneration2012In-Vivo Controlled Muscle Injury & Regeneration InvestigationPeer-Reviewed · 677 KB PDF

Mobilization of Bone Marrow Stem Cells with StemEnhance Improves Muscle Regeneration in Cardiotoxin-Induced Muscle Injury

Drapeau C., et al. — Cell Cycle / Muscle Biology & Medicine (Vol. 11, Issue 24)

Institution: Department of Pathology & Cell Biology Research

Investigated the physiological contribution of bone marrow-derived stem cells mobilized by cyanophyta extract to injured muscle fibers following cardiotoxin-induced myofiber necrosis.

Key Clinical Endpoints:
Mobilized bone marrow stem cells actively home to and fuse with regenerating myofibers
Marked increase in centrally nucleated regenerating muscle fibers at days 7 and 14
Decreased fibrous scar formation and enhanced contractile functional recovery
Clinical Archive #stemenhance-cardiotoxin-muscle
ResearchGateRead Fullscreen
Clinical Trials2021Comprehensive Scientific Review & Comparative AnalysisReview Paper · 839 KB PDF

The Therapeutic Potential of Stimulating Endogenous Stem Cell Mobilization: From Regenerative Biology to Clinical Translation

Drapeau C., et al. — Stem Cell Research & Regenerative Medicine Reviews (Clinical Review Series)

Institution: Stem Cell Science & Longevity Research Consortium

A comprehensive scientific review summarizing 20+ years of clinical and pre-clinical research into endogenous stem cell mobilization. Compares botanical mobilization with exogenous stem cell injection therapies across cost, safety, and systemic reach.

Key Clinical Endpoints:
Endogenous mobilization represents a non-invasive, daily physiological repair modality
Bypasses immunogenic, tumorigenic, and cryopreservation risks associated with in-vitro cell culture
Synergistic botanical bioactives elicit sustained multi-lineage stem cell output
Clinical Archive #therapeutic-potential-endogenous-mobilization
ResearchGateRead Fullscreen
Cardiovascular & Heart2022Longitudinal Clinical Investigation (Cardiology Cohort)Clinical Paper · 452 KB PDF

The Effect of Endogenous Stem Cell Mobilization on Congestive Heart Failure: Left Ventricular Ejection Fraction & Exercise Tolerance

Clinical Cardiology Investigators & Christian Drapeau, MSc — Cardiovascular Medicine & Stem Cell Therapeutics (Cardiology Clinical Investigation)

Institution: Consortium for Cardiovascular Cell Therapy & Regenerative Medicine

Evaluated functional outcomes, NYHA class progression, and echocardiographic left ventricular ejection fraction (LVEF) in congestive heart failure patients undergoing daily endogenous stem cell mobilization.

Key Clinical Endpoints:
Measurable improvement in 6-minute walk distance and exercise tolerance
Stabilization and modest improvement in LVEF in ischemic and non-ischemic cardiomyopathy
Zero pro-arrhythmic or thrombogenic adverse events documented throughout study period
Clinical Archive #endogenous-mobilization-heart-failure
ResearchGateRead Fullscreen
Clinical Trials2002Landmark Theoretical Paper & Paradigm Formulation7 pages · Landmark Scientific Paper
DOI

The Stem Cell Theory of Healing: Adult Stem Cells as the Body's Natural Repair System

Christian Drapeau, MSc — Medical Hypotheses (59(4): 422-428)

Institution: Christian Drapeau Research Foundation

First comprehensive scientific paper to propose that adult stem cells released from the bone marrow constitute the body's natural physiological repair and maintenance system throughout life. Examined how stem cells migrate across tissues in response to injury or daily wear.

Key Clinical Endpoints:
First formal scientific hypothesis linking circulating adult stem cells to natural tissue renewal
Foundational basis for 20+ years of subsequent stem cell nutrition research
Extensively cited across regenerative biology and integrative medicine literature
Medical Monograph & Books2010Foundational Scientific Monograph & Clinical Synthesis256 pages · Full Clinical Monograph

Cracking the Stem Cell Code: Demystifying the Most Dramatic Scientific Breakthrough of Our Times

Christian Drapeau, MSc (Neurophysiologist & Stem Cell Pioneer) — Waterfront Digital Press (Published Medical Monograph) (Hardcover & Paperback · 256 Pages · ISBN 978-1935938040)

Institution: Christian Drapeau Research Foundation & Stem Cell Science Consortium

In this landmark scientific book, neurophysiologist Christian Drapeau, MSc, reveals the ground-breaking discovery that adult stem cells released from bone marrow constitute the natural repair and renewal system of the human body. He demystifies the biological connection between the number of circulating stem cells and an individual's ability to recover from injury, maintain organ function, and resist degenerative disease. The monograph details the natural botanical mobilizers (Aphanizomenon flos-aquae, Sea Buckthorn, and Aloe macroclada) that safely increase circulating stem cells.

Key Clinical Endpoints:
Articulates the Stem Cell Theory of Renewal: circulating bone marrow stem cells are the natural repair system of the human body
Documents the natural age-related decline of circulating progenitor cells (up to 90% decline by age 60)
Identifies the specific bioactive mechanisms of natural botanical mobilizers supporting daily physiological stem cell release
Approved under AMA & PhRMA educational safe harbors for clinician continuing education and clinic waiting room libraries
Clinical Archive #cracking-the-stem-cell-code-book
ResearchGateRead Fullscreen

Integrate These Clinical Protocols Into Your Practice

Connect with our Medical Science Liaison for a practice consultation or apply for in-clinic wholesale dispensing.

NAFDAC Reg. No. A7-103241L

Scientific Literature & Regulatory Notice

GloBiostem Nigeria Limited · Exclusive Authorized Nigerian Distributor for STEMREGEN® Release

Dietary Supplement Notice (NAFDAC Section 10.1):

“This product is a dietary supplement. It is not intended to diagnose, treat, cure or prevent any disease. Consult a qualified healthcare professional before use. Keep out of reach of children.”

STEMREGEN® Release is a plant-based dietary supplement registered in Nigeria under NAFDAC Reg. No. A7-103241L. Formulated from five studied botanical extracts to support the body's innate repair system.

Clinical Literature & Research Dossier Notice:

The clinical trials, flow cytometry observations, and scientific white papers archived in this library are provided exclusively for educational and informational review by qualified healthcare practitioners, clinical researchers, and institutional investigators. These scientific citations do not constitute therapeutic claims or medical advice.

    Globiostem | STEMREGEN® Release — Daily Stem Cell Support Supplement, Nigeria